Type: (null)
Journal: Lancet, The
Year: 2013
Pages: 382, 1021-1028
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
Distribution of the number of citations over years.

Authors

#AuthorsArticlesCitationsh-index
1Evandro De Azambuja27919812279
2Christian Jackisch681734268
3David A Cameron18233136182
4Michael Untch481987348
5Luca Gianni13537037135
6Michael Andersson44648244